Wird geladen...

Antibody–drug conjugates in solid tumors: a look into novel targets

Antibody–drug conjugates (ADCs) are a relatively new class of anticancer agents designed to merge the selectivity of monoclonal antibodies with cell killing properties of chemotherapy. They are commonly described as the “Trojan Horses” of therapeutic armamentarium, because of their capability of dir...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Hematol Oncol
Hauptverfasser: Criscitiello, Carmen, Morganti, Stefania, Curigliano, Giuseppe
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7844898/
https://ncbi.nlm.nih.gov/pubmed/33509252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-021-01035-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!